These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Williams K Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753 [TBL] [Abstract][Full Text] [Related]
4. Effects of remifentanil on N-methyl-D-aspartate receptor: an electrophysiologic study in rat spinal cord. Guntz E; Dumont H; Roussel C; Gall D; Dufrasne F; Cuvelier L; Blum D; Schiffmann SN; Sosnowski M Anesthesiology; 2005 Jun; 102(6):1235-41. PubMed ID: 15915038 [TBL] [Abstract][Full Text] [Related]
5. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites. Woodward RM; Huettner JE; Guastella J; Keana JF; Weber E Mol Pharmacol; 1995 Mar; 47(3):568-81. PubMed ID: 7700254 [TBL] [Abstract][Full Text] [Related]
6. Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes. Avenet P; Léonardon J; Besnard F; Graham D; Frost J; Depoortere H; Langer SZ; Scatton B Eur J Pharmacol; 1996 Jan; 296(2):209-13. PubMed ID: 8838458 [TBL] [Abstract][Full Text] [Related]
8. Local anaesthetics inhibit signalling of human NMDA receptors recombinantly expressed in Xenopus laevis oocytes: role of protein kinase C. Hahnenkamp K; Durieux ME; Hahnenkamp A; Schauerte SK; Hoenemann CW; Vegh V; Theilmeier G; Hollmann MW Br J Anaesth; 2006 Jan; 96(1):77-87. PubMed ID: 16299047 [TBL] [Abstract][Full Text] [Related]
9. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine. Williams K Mol Pharmacol; 1994 Sep; 46(3):531-41. PubMed ID: 7935335 [TBL] [Abstract][Full Text] [Related]
10. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes. Avenet P; Léonardon J; Besnard F; Graham D; Depoortere H; Scatton B Neurosci Lett; 1997 Feb; 223(2):133-6. PubMed ID: 9089691 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of recombinant N-methyl-D-aspartate (NMDA) receptors containing the epsilon 4 (NR2D) subunit. Williams K Neurosci Lett; 1995 Jan; 184(3):181-4. PubMed ID: 7715842 [TBL] [Abstract][Full Text] [Related]
12. Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors. Kloda A; Clements JD; Lewis RJ; Adams DJ Mol Pharmacol; 2004 Jun; 65(6):1386-96. PubMed ID: 15155832 [TBL] [Abstract][Full Text] [Related]
13. Direct Effect of Remifentanil and Glycine Contained in Ultiva® on Nociceptive Transmission in the Spinal Cord: In Vivo and Slice Patch Clamp Analyses. Sumie M; Shiokawa H; Yamaura K; Karashima Y; Hoka S; Yoshimura M PLoS One; 2016; 11(1):e0147339. PubMed ID: 26771515 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells. Priestley T; Laughton P; Myers J; Le Bourdellés B; Kerby J; Whiting PJ Mol Pharmacol; 1995 Nov; 48(5):841-8. PubMed ID: 7476914 [TBL] [Abstract][Full Text] [Related]
15. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells. Bresink I; Benke TA; Collett VJ; Seal AJ; Parsons CG; Henley JM; Collingridge GL Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398 [TBL] [Abstract][Full Text] [Related]